How Quality Sleep Can Reduce the Risk of Heart Disease and Stroke

Translate to Spanish or other 102 languages!

Experts say a quiet and dark bedroom are two keys to getting healthy sleep every night. Image for illustration purposes
- Advertisement -
  • Researchers report that better sleep may translate into a lower risk of cardiovascular disease.
  • They add that consistent and healthy sleep patterns can improve a person’s overall well-being.
  • Experts say people having trouble sleeping should rethink pre-sleep activities and avoid stimulation before bedtime.

studyTrusted Source published in the journal JAMA Network Open reports that midlife and older adults with healthy sleep habits have a better chance of avoiding cardiovascular disease.

Follow the link Below to Medical News Today to read the full Story:

https://www.medicalnewstoday.com/articles/how-quality-sleep-can-reduce-the-risk-of-heart-disease-and-stroke?slot_pos=article_1&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-04-25&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

How Dogs Benefit Mind and Soul

"Dogs are wonderful greeters. They're waiting for you to come home, and they're always happy to see you. In turn, this increases our feel-good hormones, like dopamine and serotonin,” explained Chivonna Childs, PhD.

Data Reveals US Illicit Fentanyl Use is Double That of Clinical Care

The largest study to date that quantifies and compares medical and illegal use of fentanyl in the United States suggests that illicit use is more than twice as common as medically based use. 

7 Crucial Caregiving Truths Families Often Overlook

If you clicked to read this story, or someone sent it to you, congratulations: You’re a caregiver.

Moderna and Merck Report Positive Phase 3 Results for Personalized Cancer Therapy

Moderna and Merck have reached a major clinical milestone after their investigational individualized cancer therapy, combined with Merck’s Keytruda, produced positive results in a Phase 3 study involving patients with high-risk melanoma.
- Advertisement -